These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 34655569)

  • 1. Novel Mechanisms Targeted by Drug Trials in Pulmonary Arterial Hypertension.
    Condon DF; Agarwal S; Chakraborty A; Auer N; Vazquez R; Patel H; Zamanian RT; de Jesus Perez VA
    Chest; 2022 Apr; 161(4):1060-1072. PubMed ID: 34655569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Systematic Review of Novel Therapies of Pulmonary Arterial Hypertension.
    Nabeh OA; Saud AI; Amin B; Khedr AS; Amr A; Faoosa AM; Esmat E; Mahmoud YM; Hatem A; Mohamed M; Osama A; Soliman YMA; Elkorashy RI; Elmorsy SA
    Am J Cardiovasc Drugs; 2024 Jan; 24(1):39-54. PubMed ID: 37945977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial cells in the pathogenesis of pulmonary arterial hypertension.
    Evans CE; Cober ND; Dai Z; Stewart DJ; Zhao YY
    Eur Respir J; 2021 Sep; 58(3):. PubMed ID: 33509961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promising therapeutic approaches in pulmonary arterial hypertension.
    Ali MK; Ichimura K; Spiekerkoetter E
    Curr Opin Pharmacol; 2021 Aug; 59():127-139. PubMed ID: 34217109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The treatment strategy of connective tissue disease associated pulmonary arterial hypertension: Evolving into the future.
    Zhao J; Wang Q; Deng X; Qian J; Tian Z; Liu Y; Li M; Zeng X
    Pharmacol Ther; 2022 Nov; 239():108192. PubMed ID: 35461923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evolution of pathogenetic therapy of pulmonary arterial hypertension].
    Chazova IE; Yarovoy SY; Danilov NM
    Ter Arkh; 2019 Dec; 91(12):4-9. PubMed ID: 32598582
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Peng Y; Dai J; Zhao YY
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in the discovery of drugs that treat pulmonary arterial hypertension.
    Zolty R
    Expert Opin Drug Discov; 2023 Apr; 18(4):445-466. PubMed ID: 37013267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Drugs and Therapies in Pulmonary Arterial Hypertension.
    Shah AJ; Beckmann T; Vorla M; Kalra DK
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurohormonal modulation in pulmonary arterial hypertension.
    Peters EL; Bogaard HJ; Vonk Noordegraaf A; de Man FS
    Eur Respir J; 2021 Oct; 58(4):. PubMed ID: 33766951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing Pulmonary Arterial Hypertension With Cardiopulmonary Comorbidities.
    Provencher S; Mai V; Bonnet S
    Chest; 2024 Mar; 165(3):682-691. PubMed ID: 38461018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging biologics for the treatment of pulmonary arterial hypertension.
    Hye T; Hossain MR; Saha D; Foyez T; Ahsan F
    J Drug Target; 2023 Jun; 31(5):1-15. PubMed ID: 37026714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Molecular Mechanisms Involved in the Medical Treatment of Pulmonary Arterial Hypertension.
    Martin de Miguel I; Cruz-Utrilla A; Oliver E; Escribano-Subias P
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Biomarkers in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension.
    Moccaldi B; De Michieli L; Binda M; Famoso G; Depascale R; Perazzolo Marra M; Doria A; Zanatta E
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. iPSC-endothelial cell phenotypic drug screening and in silico analyses identify tyrphostin-AG1296 for pulmonary arterial hypertension.
    Gu M; Donato M; Guo M; Wary N; Miao Y; Mao S; Saito T; Otsuki S; Wang L; Harper RL; Sa S; Khatri P; Rabinovitch M
    Sci Transl Med; 2021 May; 13(592):. PubMed ID: 33952674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sotatercept for Pulmonary Arterial Hypertension in the Inpatient Setting.
    Torbic H; Tonelli AR
    J Cardiovasc Pharmacol Ther; 2024; 29():10742484231225310. PubMed ID: 38361351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of pulmonary arterial hypertension during pregnancy.
    Krishnathasan K; Constantine A; Rafiq I; Barradas Pires A; Douglas H; Price LC; Dimopoulos K
    Expert Rev Respir Med; 2023 May; 17(5):413-423. PubMed ID: 37159412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stem cell therapy for pulmonary arterial hypertension: An update.
    Sun QW; Sun Z
    J Heart Lung Transplant; 2022 Jun; 41(6):692-703. PubMed ID: 35341679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Connexin43, A Promising Target to Reduce Cardiac Arrhythmia Burden in Pulmonary Arterial Hypertension.
    Sykora M; Szeiffova Bacova B; Andelova K; Egan Benova T; Martiskova A; Kurahara LH; Hirano K; Tribulova N
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted therapies in pulmonary arterial hypertension.
    Montani D; Chaumais MC; Guignabert C; Günther S; Girerd B; Jaïs X; Algalarrondo V; Price LC; Savale L; Sitbon O; Simonneau G; Humbert M
    Pharmacol Ther; 2014 Feb; 141(2):172-91. PubMed ID: 24134901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.